IGC Pharma, Inc. (IGC) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师预估 每股收益(EPS)为 $-0.21 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.22 vs 预期 $-0.21 (不及预期 -5.5%). 2025: 实际 $-0.09 vs 预期 $-0.10 (超预期 +6.9%). 分析师准确度: 94%.
IGC 分析师评级
Buy
基于过去3个月内 2 位分析师对 IGC Pharma, Inc. 的评级
EPS 预测 — IGC
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.22
vs Est –$0.21
▼ 5.2% off
2025
Actual –$0.09
vs Est –$0.10
▲ 7.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — IGC
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.001B
vs Est $0.001B
▲ 21.0% off
2025
Actual $0.001B
vs Est $0.001B
▲ 2.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
